Capforce Inc Revenue Growth Rates (CFOR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Capforce Inc   (CFOR)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

CFOR's Revenue Growth by Quarter and Year

Capforce Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CFOR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 50.00
1st Quarter March 0.00
FY 50.00

CFORs Annual Revenue
Capforce Inc 's Revenue in the fiscal year 2025 $ 30.20 millions
Capforce Inc 's Revenue in the fiscal year 2024 $ 5.20 millions
Capforce Inc 's Revenue in the fiscal year 2023 $ 3.42 millions
Capforce Inc 's Revenue in the fiscal year 2022 $ 2.61 millions
Capforce Inc 's Revenue in the fiscal year 2021 $ 4.31 millions




CFOR Revenue second quarter 2026 Y/Y Growth Comment
Capforce Inc achieved in the second quarter 2026, above Company average Revenue surge of 1150% year on year, to $ 50.00 millions.

According to the results reported in the second quarter 2026, Capforce Inc achieved the best Revenue growth in Medical Laboratories industry. While Capforce Inc ' s Revenue doubling of 1150% ranks overall at the positon no. 44 in the second quarter 2026.


CFOR Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 424 % 367.29 % 48.61 %
3rd Quarter September - - - 55.56 %
2nd Quarter June 1150 % 13233.33 % -95.95 % -23.71 %
1st Quarter March - - -81.32 % 93.62 %
FY   - 480.77 % 52.05 % -

Financial Statements
Capforce Inc 's second quarter 2026 Revenue $ 50.00 millions CFOR's Income Statement
Capforce Inc 's second quarter 2025 Revenue $ 4.00 millions Quarterly CFOR's Income Statement


CFOR Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - - - 52.86 %
3rd Quarter September - - - -5.41 %
2nd Quarter June - - -82.35 % -18.68 %
1st Quarter March - - -84.11 % 26.39 %
FY (Year on Year)   - 480.77 % 52.05 % -


Back to CFOR Growth rate Comparisons >> Back to CFOR Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #17
Overall #44

Revenue Y/Y Growth Statistics
High Average Low
14185.71 % 371.02 % -100 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #17
Overall #44
Revenue Y/Y Growth Statistics
High Average Low
14185.71 % 371.02 % -100 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Capforce Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CFOR's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CFOR's II. Quarter Q/Q Revenue Comment


Capforce Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Jun 30 2026 period, Capforce Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Capforce Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2026 period, Capforce Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Capforce Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CFOR's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Liquidia Corporation1,842.73%$ 1,842.729 millions
Verastem Inc 1,775.43%$ 1,775.433 millions
EBR Systems, Inc.1,453.92%$ 1,453.919 millions
Safe Pro Group Inc 1,336.15%$ 1,336.152 millions
Capforce Inc 1,150.00%$ 1,150.000 millions
Crispr Therapeutics Ag1,041.37%$ 1,041.368 millions
Arvinas Inc 1,014.73%$ 1,014.732 millions
Abeona Therapeutics Inc 697.48%$ 697.477 millions
Nuvation Bio Inc 644.35%$ 644.350 millions
Tonix Pharmaceuticals Holding Corp 577.88%$ 577.878 millions


About Capforce Inc Revenue Growth Rates (CFOR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Capforce Inc (CIK 1293818).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001829126-26-009079
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Capforce Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.